Insider Trading April 7, 2026

Intellicheck CEO Executes Planned Sale, Gifts Additional Shares Amid Strong Q4 Results

Bryan Lewis sells 10,000 shares under a 10b5-1 plan and gifts 80,000 shares to family trust as company posts record quarterly revenue and EPS beat

By Ajmal Hussain IDN
Intellicheck CEO Executes Planned Sale, Gifts Additional Shares Amid Strong Q4 Results
IDN

Intellicheck CEO Bryan Lewis sold 10,000 shares on April 6, 2026, at $7.5254 under a Rule 10b5-1 plan and transferred 80,000 shares to The Lewis Family Revocable Living Trust. The stock is trading near its 52-week high after a 221% year-over-year gain, and the company reported Q4 2025 results that exceeded expectations on both earnings and revenue.

Key Points

  • Intellicheck CEO Bryan Lewis sold 10,000 shares at $7.5254 on April 6, 2026, via a Rule 10b5-1 plan.
  • Lewis gifted 80,000 shares to The Lewis Family Revocable Living Trust on the same day; he directly owns 327,126 shares following the transactions.
  • Intellicheck reported Q4 2025 EPS of $0.08 and revenue of $6.635 million, beating analysts' estimates; DA Davidson and H.C. Wainwright reiterated Buy ratings.

Transaction details

On April 6, 2026, Bryan Lewis, CEO and President of Intellicheck, Inc. (NASDAQ: IDN), sold 10,000 shares of common stock at a price of $7.5254 per share, resulting in proceeds of $75,254. The sale was executed indirectly through The Lewis Family Revocable Living Trust under a Rule 10b5-1 trading plan.

According to the Form 4 filed with the Securities and Exchange Commission, the trading plan was adopted by the trust prior to April 6, 2026. The plan’s selling start date is listed as April 6, 2026, and its end date is July 31, 2026. In the filing, Lewis disclaims beneficial ownership of the shares sold through the trust.

Concurrent gift and ownership position

On the same day as the sale, Lewis gifted 80,000 shares of Intellicheck common stock to The Lewis Family Revocable Living Trust. Following these transactions, Lewis is reported to directly own 327,126 shares of Intellicheck, Inc.

Market context

The sale occurred while Intellicheck’s stock was trading close to its 52-week high of $7.99, after a reported 221% increase in the share price over the last year. Separate analysis noted in the filing indicated the stock may be overvalued relative to its Fair Value, though details of that valuation were not provided in the SEC filing.

Company financials and analyst response

Intellicheck released fourth-quarter 2025 financial results that surpassed market expectations. The company reported earnings per share of $0.08 for the quarter, above the projected $0.0233. Revenue for Q4 reached $6.635 million, exceeding the forecasted $6.2 million and representing a record for both the quarter and the full year.

Following the results, DA Davidson reiterated a Buy rating on Intellicheck and maintained a price target of $7.50, citing strong performance in revenue, EBITDA, and earnings per share. H.C. Wainwright also reiterated a Buy rating, raising its price target to $8.50 and noting Intellicheck’s revenue of $6.6 million, which exceeded their estimate of $6.3 million. The company reported a 25% quarter-over-quarter increase in retail revenue, attributed in the filings to seasonal strength in the retail sector.

Analysts' reiterated Buy ratings and the stronger-than-expected financial metrics were noted as reinforcing investor confidence and indicative of Intellicheck’s position in the market.


Note on limitations

Where specific valuation methodology or additional supporting detail was referenced in filings or ancillary analysis, those materials were not reproduced in full in the SEC filing referenced above.

Risks

  • Insider transactions such as the sale and gift may be viewed variably by investors and can affect perception of insider alignment - impacts investor sentiment in equity markets.
  • Valuation concerns were raised in an analysis referenced in filings, which suggests the stock may be overvalued relative to its Fair Value - impacts equity valuation assessments for Intellicheck.
  • Seasonal swings, cited as contributing to a 25% quarter-over-quarter retail revenue increase, introduce uncertainty in sustaining that revenue level beyond seasonal effects - impacts revenue predictability in the retail-facing segments.

More from Insider Trading

Lipocine Director Increases Stake as Stock Sits Near 52-Week Low Apr 7, 2026 Travere Therapeutics Director Sells $330,000 in Stock, Exercises Options for Additional Shares Apr 7, 2026 Perdoceo General Counsel Sells $1.14 Million in Stock as Board Confirms 2026 Incentive Plan Apr 7, 2026 Cathay General Bancorp CEO Executes $243,505 Stock Sale Under 10b5-1 Plan Apr 7, 2026 Guardant Health Chief People Officer Disposes of $355K in Shares Amid Rising Stock Apr 7, 2026